(1R,3R)-3-(4-(1H-indol-3-yl)-1H-imidazol-2-yl)-1-(tetrahydro-2H-pyran-4-yl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole

ID: ALA3775643

PubChem CID: 127032663

Max Phase: Preclinical

Molecular Formula: C27H27N5O

Molecular Weight: 437.55

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  c1ccc2c(-c3c[nH]c([C@H]4Cc5c([nH]c6ccccc56)[C@@H](C5CCOCC5)N4)n3)c[nH]c2c1

Standard InChI:  InChI=1S/C27H27N5O/c1-3-7-21-18(6-1)20(14-28-21)24-15-29-27(32-24)23-13-19-17-5-2-4-8-22(17)30-26(19)25(31-23)16-9-11-33-12-10-16/h1-8,14-16,23,25,28,30-31H,9-13H2,(H,29,32)/t23-,25-/m1/s1

Standard InChI Key:  UAAOHFNDGBMJOG-ILBGXUMGSA-N

Molfile:  

     RDKit          2D

 33 39  0  0  0  0  0  0  0  0999 V2000
   -3.7006    0.8244    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7006   -0.6045    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4915   -1.3190    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4915    1.5389    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2274    0.8244    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2274   -0.6045    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000   -1.3190    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.2274    0.8244    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2274   -0.6045    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4732   -1.3190    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7372   -0.6045    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.7372    0.8244    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4732    1.5389    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0335    1.5807    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1716    3.0613    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.6389    3.3729    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3886    2.0737    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3847    0.9592    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.4684   -2.8198    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7672   -3.5709    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7663   -5.0709    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4668   -5.8201    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.1682   -5.0693    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1691   -3.5693    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.8811    1.9165    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.5054    0.5633    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.9654    0.7602    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.9396    2.9455    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2501    2.2261    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.5443    2.9924    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.5046    4.5116    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.1941    5.2310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8912    4.4487    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  6  2  0
  5  4  2  0
  4  1  1  0
  5  6  1  0
  6  7  1  0
  7  9  1  0
  8  5  1  0
  8  9  2  0
  8 13  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 14 15  1  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 14  2  0
 12 14  1  6
 19 20  1  0
 19 24  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 10 19  1  6
 25 26  2  0
 26 27  1  0
 27 29  1  0
 28 25  1  0
 17 25  1  0
 28 29  2  0
 29 30  1  0
 30 31  2  0
 31 32  1  0
 32 33  2  0
 33 28  1  0
M  END

Alternative Forms

  1. Parent:

    ALA3775643

    ---

Associated Targets(Human)

SSTR3 Tclin Somatostatin receptor 3 (1562 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KCNH2 Tclin HERG (29587 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 437.55Molecular Weight (Monoisotopic): 437.2216AlogP: 5.39#Rotatable Bonds: 3
Polar Surface Area: 81.52Molecular Species: NEUTRALHBA: 3HBD: 4
#RO5 Violations: 1HBA (Lipinski): 6HBD (Lipinski): 4#RO5 Violations (Lipinski): 1
CX Acidic pKa: 12.46CX Basic pKa: 7.48CX LogP: 4.09CX LogD: 3.75
Aromatic Rings: 5Heavy Atoms: 33QED Weighted: 0.31Np Likeness Score: 0.08

References

1. He S, Dobbelaar PH, Guo L, Ye Z, Liu J, Jian T, Truong Q, Shah SK, Du W, Qi H, Bakshi RK, Hong Q, Dellureficio JD, Sherer E, Pasternak A, Feng Z, Reibarkh M, Lin M, Samuel K, Reddy VB, Mitelman S, Tong SX, Chicchi GG, Tsao KL, Trusca D, Wu M, Shao Q, Trujillo ME, Fernandez G, Nelson D, Bunting P, Kerr J, Fitzgerald P, Morissette P, Volksdorf S, Eiermann GJ, Li C, Zhang BB, Howard AD, Zhou YP, Nargund RP, Hagmann WK..  (2016)  SAR exploration at the C-3 position of tetrahydro-β-carboline sstr3 antagonists.,  26  (6): [PMID:26898814] [10.1016/j.bmcl.2016.02.022]

Source